• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. (SPARKS) BD BBL¿ TRYPTICASE¿ SOY BROTH; CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. (SPARKS) BD BBL¿ TRYPTICASE¿ SOY BROTH; CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL Back to Search Results
Model Number 221093
Device Problem Inaccurate Information (4051)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/19/2021
Event Type  malfunction  
Manufacturer Narrative
Initial reporter phone number: (b)(6).A device evaluation and/or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.
 
Event Description
It was reported that while using bd bbl¿ trypticase¿ soy broth incorrect label information was observed by the laboratory personnel.There was no report of patient impact.The following information was provided by the initial reporter: " customer problem: customer reporting lot number on tube labels doesn¿t match lot number on packaging labels for product 221093".
 
Manufacturer Narrative
H.6.Investigation: material 221093 is manufactured by rehydrating the media components with usp purified water, and thoroughly mixing until a homogeneous solution is obtained.The tubes are filled, capped, torqued and then labeled by machine per standard operating procedure (sop).The tubes are terminally autoclaved in an air over pressure (aop) autoclave, per manufacturing instructions, using a validated cycle.Post autoclaving, tubes are packaged into final shipping configurations.The batch history record review for batch 0245498 was satisfactory per internal procedures.Formulation, filling and labeling processes were within specifications.Qc inspection and testing were satisfactory at time of release.The complaint history was reviewed, and no other complaints have been taken on this batch.Retention samples from batch 0245498 (10 tubes) were available for inspection.No labeling defects were observed in 10/10 retention samples.The labeling process for material 221093 includes label reconciliation where the total number of labels issued is reconciled with the total quantity of labels applied to tubes, affixed to the batch history record, rejected and unused.Any discrepancies must be within allowable limits specified in the labeling control procedure.The label reconciliation for batch 0245498 shows there was not a shortage or excess of labels after the manufacturing.Two photos were received to assist with the investigation: the first photo shows a packaging label on a shipping box.The second photo shows a tube from batch 0245498.Also noted is a shipping receipt for batch 0294209.No other observations can be made from the photos.The product is not mislabeled, either the wrong shipping receipt or product was received with the order.No returns were received to assist with the investigation.The complaint cannot be confirmed by the photos provided.Bd will continue to trend complaints for labeling.H3 other text : see h.10.
 
Event Description
It was reported that while using bd bbl¿ trypticase¿ soy broth incorrect label information was observed by the laboratory personnel.There was no report of patient impact.The following information was provided by the initial reporter: " customer problem: customer reporting lot number on tube labels doesn¿t match lot number on packaging labels for product 221093".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD BBL¿ TRYPTICASE¿ SOY BROTH
Type of Device
CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL
Manufacturer (Section D)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer (Section G)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer Contact
katie swenson
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key12025739
MDR Text Key269596078
Report Number1119779-2021-01004
Device Sequence Number1
Product Code JSG
UDI-Device Identifier30382902210932
UDI-Public30382902210932
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 10/25/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date03/02/2022
Device Model Number221093
Device Catalogue Number221093
Device Lot Number0245498
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/20/2021
Initial Date FDA Received06/18/2021
Supplement Dates Manufacturer Received10/25/2021
Supplement Dates FDA Received11/09/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/01/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-